The chart was, in truth, a parody of analysis. Even the presenter acknowledged it was unlikely. But that was never the point. The intent was to frame stakeholder calls for greater investment in innovative health technologies as a direct threat to national solvency. The underlying message was clear. The demand is against the national interest. …
The continued 'false framing' aims to make us feel guilty for wanting more on health
October 31, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
LifeSciences Australia honours outstanding professionals at MTP Sector Awards 2026
June 12, 2026 - - Latest News -
'The changes could cause irreversible damage to our vibrant and world-leading biotech, medtech and health tech sector'
June 12, 2026 - - Australian Biotech -
The opportunity to change the conversation, the negotiating dynamic, and take some control
June 12, 2026 - - Latest News -
State and Territory ministers warn against centralising NDIS power
June 12, 2026 - - Latest News -
ARCS evolves into LifeSciences Australia as part of wider strategic change
June 11, 2026 - - Latest News -
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - - Latest News -
Island secures US partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech